Correspondence 0001213900-23-028701 from Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd.
Date: April 11, 2023 · CIK: 0001871321 · Accession: 0001213900-23-028701
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271073
Letter
April 11, 2023
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
Re: Alpha Tau Medical Ltd.
Registration Statement on Form F-3
Filed April 3, 2023
Registration No. 333-271073
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on April 13, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham & Watkins LLP, counsel to the Company, at (212) 906-1829, or in his absence, Nathan Ajiashvili at (212) 906-2916, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
[Signature Page Follows]
Sincerely yours,
Alpha Tau Medical Ltd.
Show Raw Text
CORRESP
1
filename1.htm
April 11, 2023
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
Re:
Alpha Tau Medical Ltd.
Registration Statement on Form F-3
Filed April 3, 2023
Registration No. 333-271073
Ladies and Gentlemen:
In accordance with Rule
461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration
of the effective date of the above-referenced Registration Statement so that it will become effective on April 13, 2023, at 4:00 p.m.,
Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the “Company”)
or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham & Watkins LLP, counsel to
the Company, at (212) 906-1829, or in his absence, Nathan Ajiashvili at (212) 906-2916, to provide notice of effectiveness, or if you
have any other questions or concerns regarding this matter.
[Signature Page Follows]
Sincerely yours,
Alpha Tau Medical Ltd.
By:
/s/ Uzi Sofer
Uzi Sofer
Chief Executive Officer
cc:
Michael J. Rosenberg
Nathan Ajiashvili